Subscribe
A prospective cohort study of patients offered amyloid PET as part of their dementia work-up. The results here.
Investigational Therapy TNX-102 SL Receives FDA Fast Track for Agitation in Alzheimer Disease
The Role of Diet in Brain Health
Positive Topline Results Announced for BAN2401 in Phase II Alzheimer Trial
Effects of Bioavailable Curcumin on Age-Related Cognitive Symptoms
Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD
Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA
James F. Howard Jr, MD, FAAN
Basil T. Darras, MD
Karissa Gable, MD
Anne M. Connolly, MD, FAAN; Amy Moore, PhD
Jessica Oswald, MD, MPH; Jeremy A. Adler, DMSc, PA-C; Amanda Nasser, MS, NP